Koers Carl Zeiss Meditec AG Other OTC
Aandelen
CZMWY
US14218T1051
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 2,27 mld. 2,44 mld. | Omzet 2025 * | 2,55 mld. 2,74 mld. | Marktkapitalisatie | 8,4 mld. 9,02 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 258 mln. 277 mln. | Nettowinst (verlies) 2025 * | 326 mln. 350 mln. | EV/omzet 2024 * | 3,96 x |
Nettoschuld 2024 * | 584 mln. 627 mln. | Nettoschuld 2025 * | 402 mln. 432 mln. | EV/omzet 2025 * | 3,45 x |
K/w-verhouding 2024 * |
34,1
x | K/w-verhouding 2025 * |
26,9
x | Werknemers | - |
Dividendrendement 2024 * |
1,07% | Dividendrendement 2025 * |
1,23% | Vrij verhandelbaar | 40,86% |
Recentste transcriptie over Carl Zeiss Meditec AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 31-12-21 |
Director of Finance/CFO | 59 | 01-10-18 | |
Christian Müller
BRD | Director/Board Member | 57 | 15-12-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christian Müller
BRD | Director/Board Member | 57 | 15-12-09 |
Karl Lamprecht
CHM | Chairman | 60 | 25-06-20 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 27-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,02% | 219 mld. | |
+7,85% | 184 mld. | |
+13,05% | 138 mld. | |
-1,37% | 62,54 mld. | |
+4,88% | 52,22 mld. | |
+11,51% | 51,73 mld. | |
+2,63% | 41,4 mld. | |
+5,41% | 37,17 mld. | |
+23,19% | 31,76 mld. |